pamine
Pharmaranks rates Pamine 3.5/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Pamine (Methscopolamine Bromide) is an anticholinergic used to treat Peptic Ulcer.
Methscopolamine Bromide · by Fougera Pharms
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Methscopolamine Bromide
- Drug class
- Anticholinergic
- Form
- Tablet
- Strength
- Methscopolamine Bromide 2.5MG **Federal Register Determination That Product was not Discontinued or Withdrawn for Safety or Effectiveness reasons**
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- peptic ulcer
- Manufacturer
- Fougera Pharms
- FDA application
- NDA008848
- Availability
- Discontinued (per FDA)
Drug class
How this class works, per Muscarinic Antagonists - StatPearls - NCBI Bookshelf.
May treat (source: NIH RxClass)
See how Pamine ranks — best-rated anticholinergic for:
Dosage forms
Tablet
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Pamine treat?
- Pamine (Methscopolamine Bromide) may be used to treat peptic ulcer, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How does Pamine work?
- Pamine is a anticholinergic. Anticholinergic drugs block acetylcholine, the chemical messenger of the body's "rest and digest" nervous system, by occupying its muscarinic receptors. This eases muscle spasms, dries up secretions, relaxes the bladder and airways, and speeds the heart, depending on the tissue.
- How is Pamine rated?
- pharmaranks gives Pamine a composite score of 3.5 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Pamine?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Pamine. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Pamine?
- Pamine is marketed by Fougera Pharms. You can see Fougera Pharms's full profile, rating, and other products on pharmaranks.
- Is Pamine a brand-name or generic drug?
- Pamine is a brand-name product with the active ingredient Methscopolamine Bromide.
- Is Pamine available over the counter?
- No. Pamine is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Pamine come in?
- Pamine is currently marketed as tablet, per the FDA's National Drug Code Directory.
- What class of drug is Pamine?
- Pamine is classified as anticholinergic, per the FDA's Established Pharmacologic Class.
- Is Pamine FDA-registered?
- Pamine is on record with the U.S. FDA under application number NDA008848. You can verify this on its official FDA label.
- Has Pamine been recalled by the FDA?
- Pamine has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Pamine safe?
- There's no single safe-or-not verdict. pharmaranks gives Pamine a recall-safety score of 70/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
Reviews
No reviews yet. Be the first to write one.
People also viewed
atrovent hfa
Ipratropium Bromide
spiriva respimat
Tiotropium Bromide
dicyclomine hydrochloride
Dicyclomine Hydrochloride
spiriva
Tiotropium Bromide
tudorza pressair
Aclidinium Bromide
atropine sulfate
Atropine Sulfate
Compare Pamine head-to-head
More anticholinergic drugs
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
pamine
70/100